Thank you to Chiesi for the provision of an arm’s length educational grant to support this webinar series.
Thank you to Chiesi for the provision of an arm’s length educational grant to support this webinar series.
Novel therapeutic approach to cure severe dystrophic epidermolysis bullosa
In our second webinar of 2024, Prof Katsuto Tamai, Osaka University, will be joining us to talk about his work with gene modified blister-fluid mesenchymal stromal cells for RDEB.
The webinar is free to join, but you must register.
Hosted by Sharmila Collins, founder of Cure EB, this is a free event open to all, but you must register.
There will be an opportunity to ask questions during the webinar, but please also submit your questions in advance here.
Prof Katsuto Tamai is a Professor in the Department of Stem Cell Therapy Science at Osaka University, and Director and Chief Scientific Officer of Stemrim, a biotechnology company.